Tom Williams/Lancet Haematol
Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.Aygun, B.
Lane, A.
Smart, L. R.
Santos, B.
Tshilolo, L.
Williams, T. N.
Olupot-Olupot, P.
Stuber, S. E.
Tomlinson, G.
Latham, T.
Ware, R. E.
Reach Investigators
Lancet Haematol, (2024). 11:e425-e435
Filling the data gaps on sickle cell anaemia in sub-Saharan Africa.Williams, T. N.
Lancet Haematol, (2022). 9:e172-e173
Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study.Ndila, C. M.
Uyoga, S.
Macharia, A. W.
Nyutu, G.
Peshu, N.
Ojal, J.
Shebe, M.
Awuondo, K. O.
Mturi, N.
Tsofa, B.
Sepulveda, N.
Clark, T. G.
Band, G.
Clarke, G.
Rowlands, K.
Hubbart, C.
Jeffreys, A.
Kariuki, S.
Marsh, K.
Mackinnon, M.
Maitland, K.
Kwiatkowski, D. P.
Rockett, K. A.
Williams, T. N.
Malaria, G. E. N. Consortium
Lancet Haematol, (2018). 5:e333-e345
Red blood cell variants and malaria: a long story not yet over.Williams, T. N.
Lancet Haematol, (2015). 2:e130-1
Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study.Uyoga, S.
Ndila, C. M.
Macharia, A. W.
Nyutu, G.
Shah, S.
Peshu, N.
Clarke, G. M.
Kwiatkowski, D. P.
Rockett, K. A.
Williams, T. N.
Malaria, G. E. N. Consortium
Lancet Haematol, (2015). 2:e437-44
Managing the burden of sickle-cell disease in Africa.Piel, F. B.
Rees, D. C.
Williams, T. N.
Lancet Haematol, (2014). 1:e11-2
